2176 - 2200 of 5832 Results
Title
Year
-
OPENTitle: Dysregulation of the AP2M1 phosphorylation cycle by LRRK2 impairs endocytosis and leads to dopaminergic neurodegenerationJournal Name: Science SignalingPublisher: American Association for the Advancement of Science (AAAS)Vol: 14Issue #: 693Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scisignal.abg3555Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486338Citation Count: 20
-
OPENTitle: Insomnia symptom subtypes and manifestations of prodromal neurodegeneration: a population-based study in the Canadian Longitudinal Study on AgingJournal Name: Journal of Clinical Sleep MedicinePublisher: American Academy of Sleep Medicine (AASM)Vol: 18Issue #: 2Start Page: 345End Page: 359Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.5664/jcsm.9562Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804990Citation Count: 6
-
OPENTitle: Olfaction, cholinergic basal forebrain degeneration, and cognition in early Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 90Issue #:Start Page: 27End Page: 32Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.024Best OA location URL: http://manuscript.elsevier.com/S135380202100273X/pdf/S135380202100273X.pdfCitation Count: 14
-
OPENTitle: A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathiesJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 142Issue #: 3Start Page: 399End Page: 421Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-021-02349-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-021-02349-5.pdfCitation Count: 17
-
OPENTitle: Distinct progression patterns across Parkinson disease clinical subtypesJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 8Issue #: 8Start Page: 1695End Page: 1708Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51436Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51436Citation Count: 6
-
OPENTitle: Genetic risk, adherence to a healthy lifestyle, and cognitive decline in African Americans and European AmericansJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 4Start Page: 572End Page: 580Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12435Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789942Citation Count: 26
-
OPENTitle: A high dose tango intervention for people with Parkinson's disease (PwPD)Journal Name: Advances in Integrative MedicinePublisher: Elsevier BVVol: 8Issue #: 4Start Page: 272End Page: 277Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.aimed.2021.07.005Best OA location URL: https://www.biorxiv.org/content/biorxiv/early/2019/04/18/613661.full.pdfCitation Count: 4
-
OPENTitle: Rationale and design to evaluate the PRIME Parkinson care model: a prospective observational evaluation of proactive, integrated and patient-centred Parkinson care in The Netherlands (PRIME-NL)Journal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 21Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-021-02308-3Best OA location URL: https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-021-02308-3Citation Count: 30
-
OPENTitle: Dysregulation of the Adaptive Immune System in Patients With Early-Stage Parkinson DiseaseJournal Name: Neurology Neuroimmunology & NeuroinflammationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 8Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxi.0000000000001036Best OA location URL: https://nn.neurology.org/content/nnn/8/5/e1036.full.pdfCitation Count: 67
-
OPENTitle: Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow‐upJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2257Best OA location URL: https://doi.org/10.1002/brb3.2257Citation Count: 13
-
OPENTitle: Rosmarinic Acid Potently Detoxifies Amylin Amyloid and Ameliorates Diabetic Pathology in a Transgenic Rat Model of Type 2 DiabetesJournal Name: ACS Pharmacology & Translational SciencePublisher: American Chemical Society (ACS)Vol: 4Issue #: 4Start Page: 1322End Page: 1337Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsptsci.1c00028Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369672Citation Count: 14
-
OPENTitle: The Discovery of α‐Synuclein in Lewy Pathology of Parkinson's Disease: The Inspiration of a RevolutionJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 8Start Page: 1189End Page: 1193Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13312Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13312Citation Count: 2
-
OPENTitle: BDNF rs6265 Genotype Influences Outcomes of Pharmacotherapy and Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's DiseaseJournal Name: Neuromodulation: Technology at the Neural InterfacePublisher: Elsevier BVVol: 25Issue #: 6Start Page: 846End Page: 853Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1111/ner.13504Best OA location URL: http://manuscript.elsevier.com/S1094715922000460/pdf/S1094715922000460.pdfCitation Count: 8
- International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson's Disease2021OPENTitle: International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2583End Page: 2594Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28706Best OA location URL: https://air.unimi.it/bitstream/2434/968045/2/Movement%20Disorders%20-%202021%20-%20Laansma%20-%20International%20Multicenter%20Analysis%20of%20Brain%20Structure%20Across%20Clinical%20Stages%20of.pdfCitation Count: 76
- Meaning and purpose in Huntington’s disease: a longitudinal study of its impact on quality of life2021OPENTitle: Meaning and purpose in Huntington’s disease: a longitudinal study of its impact on quality of lifeJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 8Issue #: 8Start Page: 1668End Page: 1679Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.51424Best OA location URL: http://deepblue.lib.umich.edu/bitstream/2027.42/169327/2/acn351424.pdfCitation Count: 8
-
OPENTitle: Temporal trajectory of biofluid markers in Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-94345-8Best OA location URL: https://www.nature.com/articles/s41598-021-94345-8.pdfCitation Count: 16
-
OPENTitle: Novel Approach to Movement Disorder Society–Unified Parkinson's Disease Rating Scale Monitoring in Clinical Trials: Longitudinal Item Response Theory ModelsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 7Start Page: 1083End Page: 1091Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13311Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13311Citation Count: 7
-
OPENTitle: The Experience of OFF Periods in Parkinson’s Disease: Descriptions, Triggers, and Alleviating FactorsJournal Name: Journal of Patient-Centered Research and ReviewsPublisher: Aurora Health Care, Inc.Vol: 8Issue #: 3Start Page: 232End Page: 238Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.17294/2330-0698.1836Best OA location URL: https://institutionalrepository.aah.org/cgi/viewcontent.cgi?article=1836&context=jpcrrCitation Count: 8
-
OPENTitle: Altered network stability in progressive supranuclear palsyJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 107Issue #:Start Page: 109End Page: 117Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.07.007Best OA location URL: https://doi.org/10.1016/j.neurobiolaging.2021.07.007Citation Count: 11
-
OPENTitle: Antiepileptogenesis and disease modification: Clinical and regulatory issuesJournal Name: Epilepsia OpenPublisher: WileyVol: 6Issue #: 3Start Page: 483End Page: 492Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/epi4.12526Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408600Citation Count: 24
-
OPENTitle: Lack of Association Between GBA Mutations and Motor Complications in European and American Parkinson’s Disease CohortsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 4Start Page: 1569End Page: 1578Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212657Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212657?id=journal-of-parkinsons-disease%2Fjpd212657Citation Count: 6
-
OPENTitle: Striatal Acetylcholine–Dopamine Imbalance in Parkinson Disease: In Vivo Neuroimaging Study with Dual-Tracer PET and Dopaminergic PET–Informed Correlational TractographyJournal Name: Journal of Nuclear MedicinePublisher: Society of Nuclear MedicineVol: 63Issue #: 3Start Page: 438End Page: 445Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2967/jnumed.121.261939Best OA location URL: https://jnm.snmjournals.org/content/jnumed/early/2021/07/16/jnumed.121.261939.full.pdfCitation Count: 38
-
OPENTitle: Unhealthy Behaviours and Risk of Parkinson’s Disease: A Mendelian Randomisation StudyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 4Start Page: 1981End Page: 1993Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202487Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202487?id=journal-of-parkinsons-disease%2Fjpd202487Citation Count: 32
-
OPENTitle: An implantable human stem cell-derived tissue-engineered rostral migratory stream for directed neuronal replacementJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s42003-021-02392-8Best OA location URL: https://www.nature.com/articles/s42003-021-02392-8.pdfCitation Count: 7
-
OPENTitle: The new platforms of health careJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41746-021-00478-5Best OA location URL: https://www.nature.com/articles/s41746-021-00478-5.pdfCitation Count: 15